(UroToday.com) Disparities in prostate cancer incidence and outcomes between African American and Caucasian men in the United States have been well documented. While many of the differences in outcomes are attributable to health system disparities (as evidence by equivalent outcomes when patients are treated in equal access models), emerging data suggest potential differences in the tumor genomic profile of African American and Caucasian men with advanced prostate cancer. In the Prostate, Testicular, Penile Poster session at the 2021 American Society of Clinical Oncology 2021 Annual Meeting, Dr. Pedro Barata presented their analysis of the tumor genomic landscape of African American and Caucasian men with prostate cancer, using cfDNA comprehensive genomic profiling.